TOKYO -- Taisho Pharmaceutical Holdings will be delisted following the successful completion of a tender offer from a company owned by a member of the founding family, the drugmaker announced Tuesday.
Pharmaceuticals
Japan's Taisho Pharma to go private after successful tender offer
$4.8bn management buyout for drugmaker is the nation's largest ever
A promotional event for Taisho Pharmaceutical's Lipovitan energy drink. (Photo by Makoto Taguchi)
Read Next
Latest on Pharmaceuticals
